Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   PCE(x) 39.33----

What is the latest Price to Cash Earnings (PCE) ratio of MANKIND PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of MANKIND PHARMA is 39.33 based on Mar2024 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202439.33
Mar2023-
Mar2022-
Mar2021-
Mar2020-

How is Price to Cash Earnings (PCE) of MANKIND PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2024 39.33
0
Mar2023 0
0
Mar2022 0
0
Mar2021 0
0
Mar2020 0 -

Other Financial Ratios of MANKIND PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹97,083.5 Cr -1.1% -8.1% 6.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹395,614.0 Cr -2.5% -4.7% 11.9% Stock Analytics
DIVIS LABORATORIES ₹173,533.0 Cr -2.7% -0.7% 50.4% Stock Analytics
CIPLA ₹121,439.0 Cr -1.2% 0.8% -0.9% Stock Analytics
DR REDDYS LABORATORIES ₹110,076.0 Cr -2.3% 8.2% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,066.0 Cr 1.4% -1.5% 13.3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-1.1%

-8.1%

6.5%

SENSEX

-1%

-0.9%

6.7%


You may also like the below Video Courses